You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunotherapy-naïve

Showing 1 - 25 of 4,860
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Microbiome in Immunotherapy naïve NSCLC Patients Receiving

Recruiting
  • NSCLC Stage IV
  • NSCLC, Recurrent
  • Microbiome
  • Fairway, Kansas
  • +2 more
Sep 28, 2021

Prostate Cancer Trial in Evanston, New York, Portland (Ipilimumab)

Active, not recruiting
  • Prostate Cancer
  • Evanston, Illinois
  • +2 more
Sep 9, 2021

Squamous Cell Carcinoma, Urinary Tract Cancer Trial (Atezolizumab)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Urinary Tract Cancer
  • (no location specified)
Sep 7, 2021

Extensive Stage Small Cell Lung Cancer Trial in Chicago, Indianapolis, Iowa City (Cisplatin, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Chicago, Illinois
  • +2 more
Jul 1, 2022

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • New York, New York
  • +1 more
Nov 7, 2022

Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Durvalumab (Cohort 1-3)
  • +7 more
  • Phoenix, Arizona
  • +10 more
Jan 11, 2023

Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (biological, procedure,

Recruiting
  • Lung Adenocarcinoma
  • +2 more
  • Ipilimumab
  • +5 more
  • Conroe, Texas
  • +4 more
May 25, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 13, 2022

NSCLC Stage IV Trial in France (Durvalumab)

Recruiting
  • Non-small Cell Lung Cancer Stage IV
  • Besançon, France
  • +19 more
Mar 9, 2022

Merkel Cell Carcinoma Trial in Worldwide (KRT-232, Avelumab)

Recruiting
  • Merkel Cell Carcinoma
  • Aurora, Colorado
  • +38 more
Aug 3, 2022

NSCLC Metastatic Trial in France (Ipilimumab, Nivolumab)

Active, not recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Amiens, France
  • +46 more
Mar 9, 2022

Cancer Trial in Barcelona (PBF-999)

Completed
  • Cancer
  • Barcelona, Spain
    Vall d'Hebron institute of oncology (VHIO)
Jan 24, 2023

Hepatitis B, Chronic Trial in Worldwide (HepTcell, Placebo)

Recruiting
  • Hepatitis B, Chronic
  • HepTcell
  • Placebo
  • Garden Grove, California
  • +20 more
Dec 1, 2021

Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • (no location specified)
Jun 23, 2023

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In

Recruiting
  • Lung Cancer
  • +2 more
  • Standard of care immune checkpoint inhbitors
  • Fairway, Kansas
  • +1 more
Sep 19, 2022

Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in

Terminated
Has Results
  • Advanced Pleural Malignant Mesothelioma
  • +10 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2021

Prostatic Tumors, Immunotherapy, Dendritic Cells Trial in Nijmegen (mDC vaccination, pDC vaccination, mDC and pDC vaccination)

Completed
  • Prostatic Neoplasms
  • +3 more
  • mDC vaccination
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboud University Nijmegen Medical Centre
Nov 13, 2019

Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)

Not yet recruiting
  • Merkel Cell Carcinoma
  • Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Nov 21, 2023

Lung Cancer Trial in Madrid (Microbiota Transplant plus anti PD1 therapy, anti PD1 therapy)

Recruiting
  • Lung Cancer
  • Microbiota Transplant plus anti PD1 therapy
  • anti PD1 therapy
  • Madrid, Spain
    Hospital Universitario Ramón y Cajal
Oct 3, 2022

Lung Cancer Stage IV Trial in Maastricht (Radiation)

Not yet recruiting
  • Lung Cancer Stage IV
  • Radiation
  • Maastricht, Netherlands
    Maastricht Radiation Oncology (Maastro)
Aug 29, 2023

Therapeutic Efficiency in Lung Squamous Carcinoma

Recruiting
  • Lung Neoplasm
  • +2 more
  • collect plasma samples and clinical features
  • Tianjin, Tianjin, China
    TianjinCIH
May 10, 2023

Prostate Cancer Trial in Lexington (biological, drug, radiation)

Not yet recruiting
  • Prostate Cancer
  • Pembrolizumab
  • +3 more
  • Lexington, Kentucky
    University of Kentucky
Oct 3, 2022

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023

Mantle Cell Lymphoma (MCL) Trial in Australia, Canada, United States (Acalabrutinib, Venetoclax, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma (MCL)
  • Duarte, California
  • +11 more
Jul 17, 2023

Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic Trial in Canada, United States (SLC-391, Pembrolizumab)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • +2 more
  • Indianapolis, Indiana
  • +8 more
May 5, 2023